Policy paper: Call for views on draft legislation: Supplementary Protection Certificate (SPC) waiver
There were six responses to the call for views, received from representative organisations of: rightsholders pharmaceutical innovators legal representatives, and the generic pharmaceutical industry This government response provides a summary of these responses. It sets out the response to the points raised and changes made to the proposed approach following... Continue reading